Jingbo Lu
China Pharmaceutical University(CN)State Key Laboratory of Natural Medicine
Publications by Year
Research Areas
Atherosclerosis and Cardiovascular Diseases, Cancer-related molecular mechanisms research, RNA modifications and cancer, MicroRNA in disease regulation, RNA Research and Splicing
Most-Cited Works
- → The role of the LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of autophagy flux and inflammation through mTOR-dependent signaling(2019)164 cited
- → A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis(2014)141 cited
- → An Agomir of miR-144-3p Accelerates Plaque Formation through Impairing Reverse Cholesterol Transport and Promoting Pro-Inflammatory Cytokine Production(2014)115 cited
- → mTORC1 promotes aging-related venous thrombosis in mice via elevation of platelet volume and activation(2016)97 cited
- → CCN4 Regulates Vascular Smooth Muscle Cell Migration and Proliferation(2013)70 cited
- → Long Noncoding RNA HOXC-AS1 Suppresses Ox-LDL-Induced Cholesterol Accumulation Through Promoting HOXC6 Expression in THP-1 Macrophages(2016)65 cited
- → Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change(2017)52 cited
- → MicroRNA-125b-5p attenuates lipopolysaccharide-induced monocyte chemoattractant protein-1 production by targeting inhibiting LACTB in THP-1 macrophages(2015)40 cited
- → Anti-tumor and immunomodulatory activities of an exopolysaccharide from Rhizopus nigricans on CT26 tumor-bearing mice(2016)34 cited
- → Targeting the gut microbial metabolic pathway with small molecules decreases uremic toxin production(2020)33 cited